Structured evidence table for Coq10 Blood Pressure Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Coq10 Blood Pressure Meta-Analysis | Despite major advancements in pharmacotherapies and interventional cardiology, substantial residual risk persists among patients with established disease (). | 3 | Wu Xun (2026) | Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives |
| Coq10 Blood Pressure Meta-Analysis | Additionally, many nutraceuticals are perceived to possess favorable safety and tolerability profiles compared to conventional medications, making them attractive for long-term risk reduction (). | 3 | Wu Xun (2026) | Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives |
| Coq10 Blood Pressure Meta-Analysis | Banach et al., 2018 Cicero et al., 2017 Sesso et al., 2008 However, the field is marked by heterogeneous and sometimes contradictory evidence. | 3 | Wu Xun (2026) | Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives |
| Coq10 Blood Pressure Meta-Analysis | Roth et al., 2020 Ganda et al., 2018 Visseren et al., 2021 Cardiovascular disease (CVD) is the leading cause of mortality worldwide, accounting for nearly one-third of global deaths each year (). | 3 | Wu Xun (2026) | Advances in cardiovascular supplementation: mechanisms, efficacy, and clinical perspectives |
| Coq10 Blood Pressure Meta-Analysis | 3 4 5 6 7 8 9 10 9 11 12 13 14 It is well established that aging increases the risk of developing metabolic [,], cardiovascular [,], and neurodegenerative diseases [,]. | 4 | Wiciński Michał (2026) | Review of Therapeutic Potential of Coenzyme Q10 in Ophthalmology: Focus on Age-Related Macular Degeneration, Glaucoma, and Retinitis Pigmentosa |
| Coq10 Blood Pressure Meta-Analysis | For numerous ocular diseases, aside from genetic factors and other comorbidities, advancing age constitutes a significant risk factor. | 4 | Wiciński Michał (2026) | Review of Therapeutic Potential of Coenzyme Q10 in Ophthalmology: Focus on Age-Related Macular Degeneration, Glaucoma, and Retinitis Pigmentosa |
| Coq10 Blood Pressure Meta-Analysis | This results in the development of cataracts and the decline in retinal pigment cell function associated with macular degeneration []. | 4 | Wiciński Michał (2026) | Review of Therapeutic Potential of Coenzyme Q10 in Ophthalmology: Focus on Age-Related Macular Degeneration, Glaucoma, and Retinitis Pigmentosa |
| Coq10 Blood Pressure Meta-Analysis | 1 2 Due to advancements in medical science and improvements in the quality of life, the global population is aging. | 4 | Wiciński Michał (2026) | Review of Therapeutic Potential of Coenzyme Q10 in Ophthalmology: Focus on Age-Related Macular Degeneration, Glaucoma, and Retinitis Pigmentosa |
Source documents